Wells Fargo raised the firm’s price target on Liquidia (LQDA) to $31 from $25 and keeps an Overweight rating on the shares. The firm was expecting roughly 15% upside on a good Yutrepia update, but the actual update exceeded expectations. Yutrepia is having an “exceptionally strong start” to its launch, with Tuesday’s update fundamentally changing Liquidia’s risk profile, the analyst tells investors in a research note. The firm updated its price target on increased Yutrepia estimates.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LQDA:
- Promising Outlook for Liquidia Technologies: Strong Start for Yutrepia Drives Buy Rating
- Promising Market Launch and Growth Potential for Liquidia Technologies’ Yutrepia
- Liquidia reports Q2 EPS (49c), consensus (39c)
- LQDA Earnings this Week: How Will it Perform?
- Promising Start for Liquidia Technologies: Strong Early Performance of Yutrepia